FolioMetrix’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

FolioMetrix’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$189K	Buy	+3,400	New	+$180K	0.08%	179

Other funds holding LKFT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

FolioMetrix's LKFT Position: Q2 2015 in Review

FolioMetrix opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2015: 3,400 shares worth $189K. The stake represents 0.08% of the portfolio and ranks #179 among its holdings.

41 funds tracked by Wall St. Rank hold LKFT as of Q2 2015.

FolioMetrix held 3,400 shares of Lakefront Biotherapeutics American Depositary Shares worth $189K as of Q2 2015.
Lakefront Biotherapeutics American Depositary Shares was a new FolioMetrix position in Q2 2015.
Lakefront Biotherapeutics American Depositary Shares made up 0.08% of FolioMetrix's portfolio in Q2 2015, its #179 holding.
41 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2015.

Based on FolioMetrix's 13F filing for Q2 2015, filed 5 Aug 2015.